Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF2: Daily Oral TDF/FTC PrEP in Botswana
NCT00448669Phase 3Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Mar 2007
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Centers for Disease Control and Prevention. Started Mar 2007; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00448669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448669.